Information Technology · Measuring & Controlling Devices, NEC

QSI Quantum-Si Inc SEC Filings & Insider Trading Activity 2026

company
CIK 181643184 filings
Russell 2000

QSI at a glance

Quantum-Si Inc (QSI, SEC CIK 1816431) filed its latest 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 18, 2026 and Form 4 insider filings as recently as September 23, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Quantum-Si Inc (QSI) reported revenue of $2.4 million (down 20.3% from FY2024) and a net loss of $101.3 million. Diluted EPS was -$0.51.
  • As of September 30, 2026, 17 institutional investment managers tracked by SignalX reported holding Quantum-Si Inc (QSI) shares worth $25.5 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Hawkins Jeffrey Alan on September 22, 2026 of 9,709 shares at $0.76 per share.
  • In the last 90 days, QSI insiders reported 0 open-market purchases ($0) and 6 open-market sales ($39K) on Form 4, a net sale of $39K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$2.4M
−20.3% vs prior year
Insiders · 90 days
0 buys · 6 sells
Net −$39K
13F holders
17 funds
$25.5M · −2 vs prior quarter
Latest 8-K
Nov 18, 2026
Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Q3 revenue $0.2M, down 61.6% YoY from $0.6M, driven by lower instrument and consumables volumes
  • Gross margin 34.9% vs 35.1% YoY, reflecting product mix
  • Product revenue down 65.7% YoY; service revenue down 17.0%
  • Operating cash use $64.6M for nine months, versus $78.4M YoY; marketable-securities sales drove $70.8M investing inflow
  • Cash and investments $149.4M; Proteus launch expected Q2 2027, with purchase delays pressuring 2026 revenue

Risk Factors

  • New supply-chain risk: AI-driven demand constraining semiconductors, memory, related parts, and underlying raw materials
  • Nasdaq compliance risk: $1.00 bid-price deficiency cured October 13, 2026, but future delisting remains possible
  • Product execution risk: Proteus launch delayed from end-2026 to second quarter 2027
  • Manufacturing concentration risk: Limited or sole-source suppliers could disrupt instrument and consumable deliveries
  • Regulatory risk: FDA authorization would require FDA-registered manufacturers complying with current Good Manufacturing Practice requirements

AI summary of the QSI 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 18, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Proteus development program detected all 20 naturally occurring amino acids
  • Technical milestone supports Quantum-Si’s progress toward broader protein sequencing capabilities

Item EX-99.1: Item EX-99.1

  • Proteus demonstrated single-molecule detection of all 20 amino acids, achieving QSI’s year-end 2026 goal ahead of schedule
  • Technical milestone establishes complete amino acid detection as a potential benchmark for protein sequencing
Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 and nine-month results announced for periods ended September 30, 2026
  • Business update included alongside the earnings release

Item EX-99.2: Item EX-99.2

  • Press release covers Q3 and nine months ended September 30, 2026, with results announced November 5, 2026
  • Adjusted EBITDA and adjusted total operating expenses provided as supplemental performance metrics

Item EX-99.1: Item EX-99.1

  • Q3 revenue $212,000, down from $552,000, reflecting Platinum-to-Proteus transition and near-term demand disruption
  • Proteus remains targeted for Q2 2027 launch, with 19 amino acids detected and pre-orders now open
Filed Oct 15, 2026Full analysis →

Item 8.01: Other Events

  • Nasdaq bid-price deficiency resolved as of October 13, 2026, closing the delisting matter
  • Shares regained compliance after falling below the $1.00 minimum bid-price requirement

AI summaries of QSI 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for QSI

Don't miss the next QSI filing

  • Alerts as it files. A push when QSI files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut QSI, by share count.
  • Ask anything. An AI agent that reads every QSI filing and answers with sources.

QSI alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Hawkins Jeffrey AlanSellSep 22, 2026$0.76
Keyes Jeffry R.SellSep 22, 2026$0.76
LaPointe ChristianSellSep 22, 2026$0.76
Hawkins Jeffrey AlanSellSep 21, 2026$0.76
Keyes Jeffry R.SellSep 21, 2026$0.76
LaPointe ChristianSellSep 21, 2026$0.76
Hawkins Jeffrey AlanSellJun 23, 2026$0.90
Keyes Jeffry R.SellJun 23, 2026$0.90

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$1.1M$3.1M$2.4M
Gross Profit-$1.6M$1.2M
Operating Income--$108.6M-$116.1M
Net Income--$101.0M-$101.3M
Gross Margin-52.3%47.3%
Op. Margin--3550.6%-4766.0%
Net Margin--3303.0%-4160.1%
Balance Sheet
Total Assets-$247.9M$245.6M
Equity-$215.4M$220.2M
ROE--46.9%-46.0%
Per Share
EPS-$-0.71$-0.51
Cash Flow
Operating CF--$87.8M-$94.7M
CapEx$4.5M$4.6M$2.5M

Source: XBRL data in Quantum-Si Inc (QSI)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate QSI share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
QSI shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202617$25.5M
Q2 202619$26.0M
Q1 202621$29.6M
Q4 202520$47.3M
Q3 202522$55.6M
Q2 202524$80.8M
Q1 202520$32.8M
Q4 202414$53.9M
Position changes: Q2 2026 → Q3 2026
Top Sellers
New Positions
None this quarter.
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 157 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

QSI filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 18, 2026Analysis-
8-KNov 5, 2026Analysis-
10-QNov 5, 2026Analysis
8-KOct 15, 2026Analysis-
8-KOct 8, 2026Analysis-
8-KSep 29, 2026Analysis-
4Sep 23, 2026--
4Sep 23, 2026--
4Sep 23, 2026--
10-QAug 13, 2026Analysis
8-KAug 13, 2026Analysis-
8-KJul 24, 2026Analysis-
8-KJun 24, 2026Analysis-
4Jun 24, 2026--
4Jun 24, 2026--
4Jun 24, 2026--
4Jun 24, 2026--
4May 20, 2026-
4May 20, 2026-
4May 20, 2026-
4May 20, 2026-
4May 20, 2026-
4May 20, 2026-
4May 20, 2026-
4May 20, 2026-

Related Information Technology companies

All Information Technology →

QSI SEC filings: frequently asked questions

Are QSI insiders buying or selling?

In the last 90 days, Quantum-Si Inc (QSI) officers, directors and 10% owners reported no open-market purchases and 6 open-market sales worth $39,411 by 3 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold QSI stock?

As of September 30, 2026, the largest Quantum-Si Inc (QSI) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($8.0 million), ARK Investment Management ($7.9 million), BlackRock ($5.1 million), Renaissance Technologies LLC ($1.3 million), State Street Corp ($846,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was QSI's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Quantum-Si Inc (QSI) reported revenue of $2.4 million (down 20.3% from FY2024) and a net loss of $101.3 million. Diluted EPS was -$0.51. The figures come from the XBRL data in the 10-K.

What did QSI report in its latest 8-K?

Quantum-Si Inc (QSI) filed an 8-K on November 18, 2026 reporting Item 7.01 (Regulation FD Disclosure). Proteus development program detected all 20 naturally occurring amino acids.

What are the latest QSI SEC filings?

Quantum-Si Inc (QSI) filed its latest 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 18, 2026 and a Form 4 insider filing on September 23, 2026.

What is QSI's SEC CIK number?

Quantum-Si Inc (QSI)'s SEC Central Index Key (CIK) is 1816431. EDGAR lists every QSI filing under that number.

Ask anything about QSI

The research agent reads QSI's filings, financials, insider trades and 13F holders, then answers with sources.